
Japan’s ONO Acquires US Cancer Drugmaker Deciphera for $2.4 Billion in an All-Cash Deal
Japan’s ONO Pharmaceutical Co., Ltd will acquire cancer drugmaker Deciphera Pharmaceuticals, Inc (DCPH) for $2.4 billion to expand its oncology portfolio and its presence in
Read More